Tags

Type your tag names separated by a space and hit enter

[Coagulation dysfunction in COVID-19].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(3):340-346.ZD

Abstract

In addition to common clinical features, patients with coronavirus disease 2019 (COVID-19) have varying degree of coagulation dysfunction with the risk of thrombosis and/or bleeding. COVID-19 related coagulation dysfunction is a dynamic process, which may be accompanied by the formation of disseminated intravascular coagulation and is related to the severity of the disease. The imbalance of the body's immune and inflammatory response caused by coronavirus infection is an important cause of coagulation dysfunction. Dynamic monitoring as well as early prevention and treatment are of great significance for improving the prognosis of patients. This article reviews the research progress of COVID-19 related coagulation dysfunction, to provide reference for clinical research and management.

Authors+Show Affiliations

Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

Pub Type(s)

Journal Article
Review

Language

chi

PubMed ID

32762158

Citation

Xu, Yiming, et al. "[Coagulation Dysfunction in COVID-19]." Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences, vol. 49, no. 3, 2020, pp. 340-346.
Xu Y, Lyu D, Ying K. [Coagulation dysfunction in COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(3):340-346.
Xu, Y., Lyu, D., & Ying, K. (2020). [Coagulation dysfunction in COVID-19]. Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences, 49(3), 340-346. https://doi.org/10.3785/j.issn.1008-9292.2020.04.03
Xu Y, Lyu D, Ying K. [Coagulation Dysfunction in COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(3):340-346. PubMed PMID: 32762158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Coagulation dysfunction in COVID-19]. AU - Xu,Yiming, AU - Lyu,Dandan, AU - Ying,Kejing, PY - 2020/8/8/entrez PY - 2020/8/8/pubmed PY - 2020/8/13/medline SP - 340 EP - 346 JF - Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences JO - Zhejiang Da Xue Xue Bao Yi Xue Ban VL - 49 IS - 3 N2 - In addition to common clinical features, patients with coronavirus disease 2019 (COVID-19) have varying degree of coagulation dysfunction with the risk of thrombosis and/or bleeding. COVID-19 related coagulation dysfunction is a dynamic process, which may be accompanied by the formation of disseminated intravascular coagulation and is related to the severity of the disease. The imbalance of the body's immune and inflammatory response caused by coronavirus infection is an important cause of coagulation dysfunction. Dynamic monitoring as well as early prevention and treatment are of great significance for improving the prognosis of patients. This article reviews the research progress of COVID-19 related coagulation dysfunction, to provide reference for clinical research and management. SN - 1008-9292 UR - https://www.unboundmedicine.com/medline/citation/32762158/[Coagulation_dysfunction_in_COVID-19] DB - PRIME DP - Unbound Medicine ER -